低频重复经颅磁刺激通过抑制内侧前额叶皮层减轻腹泻型肠易激综合征的内脏痛
该研究结合功能磁共振与内脏敏感性评估,发现腹泻型肠易激综合征(IBS-D)患者内侧前额叶皮层(mPFC)过度兴奋与内脏痛强相关。小鼠机制研究显示mPFC谷氨酸能神经元经NR2A依赖机制接收前扣带回伤害性输入驱动内脏痛,低频rTMS可抑制该神经元并恢复突触可塑性。临床试验验证2周mPFC靶向低频rTMS可有效缓解IBS-D患者内脏痛并改善排便习惯,效果持续至少8周。
要点
- IBS-D患者mPFC过度兴奋与内脏痛强相关
- 低频rTMS靶向mPFC可抑制谷氨酸能神经元缓解内脏痛
- 2周mPFC靶向低频rTMS改善IBS-D症状并持续至少8周
核心结论
- mPFC过度兴奋驱动IBS-D患者慢性内脏痛,低频rTMS通过抑制该过度兴奋提供镇痛,为IBS-D治疗提供基于机制的新型神经调控策略。
研究设计与样本
- 结合功能磁共振与内脏敏感性评估定位IBS-D患者脑区过度活跃。
- 在成熟IBS小鼠模型中进行机制研究。
- 开展临床试验验证rTMS对IBS-D患者的治疗潜力。
主要发现
- IBS-D患者mPFC过度兴奋与内脏痛强相关。
- IBS小鼠内脏痛由mPFC谷氨酸能神经元过度活跃驱动,该神经元经NR2A依赖机制接收前扣带回伤害性输入。
- mPFC低频rTMS通过抑制mPFC谷氨酸能神经元并恢复正常突触可塑性持续缓解IBS小鼠内脏痛。
- 2周mPFC靶向低频rTMS有效缓解IBS-D患者内脏痛并改善排便习惯,与mPFC活动降低相关,效果持续至少8周。
临床怎么用
- mPFC靶向低频rTMS可作为IBS-D内脏痛的基于机制的神经调控治疗选择。
- 2周疗程可缓解内脏痛并改善排便习惯,效果持续至少8周。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic visceral pain in IBS with diarrhoea (IBS-D) is a profound therapeutic challenge. While aberrant central processing is implicated, the key brain regions driving this visceral pain and their suitability as neuromodulatory targets remain undefined. OBJECTIVE: To identify a central hub of visceral pain in IBS-D and elucidate the mechanism by which repetitive transcranial magnetic stimulation (rTMS) confers analgesic effects. DESIGN: Combined functional MRI with visceral sensitivity assessments was used to pinpoint hyperactive brain regions of patients with IBS-D. Mechanistic studies were conducted in a well-established IBS mouse model. A clinical trial was performed to validate the therapeutic potential of rTMS in patients with IBS-D. RESULTS: Clinical observations identified hyperexcitability of the medial prefrontal cortex (mPFC) as strongly correlated with visceral pain in patients with IBS-D. In IBS mice, visceral pain was driven by the hyperactivity of mPFC glutamatergic (mPFCGlu) neurons, which received nociceptive inputs from the anterior cingulate cortex via an NR2A-dependent mechanism. Low frequency (lf)-rTMS of the mPFC sustainably alleviated visceral pain in IBS mice by inhibiting mPFCGlu neurons and restoring normal synaptic plasticity. Building on these findings, a clinical trial validated that a 2-week course of mPFC-targeted lf-rTMS in patients with IBS-D effectively alleviated visceral pain and improved bowel habits, effects associated with reduced mPFC activity and sustained for at least 8 weeks. CONCLUSIONS: Hyperexcitability of the mPFC drives chronic visceral pain in patients with IBS-D and lf-rTMS provides analgesia by suppressing this hyperactivity, offering a novel, mechanism-based neuromodulation strategy for IBS-D treatment.
引用
- Weng RX, Lin W, Sun Q, et al. Low-frequency repetitive transcranial magnetic stimulation attenuates visceral pain in IBS with diarrhoea via inhibition of the medial prefrontal cortex. Gut. 2026. PMID: 41629148. doi:10.1136/gutjnl-2025-337612
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。